Search

everythinglearnresearchcommunity

for

Search:↓

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

The CNC® prosthetic system improved body image in breast cancer patients with hair loss from chemotherapy but did not significantly change their psychological wellbeing.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

Women with PCOS may have a reduced ability to fight breast tumor cells over time.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

The document explains how to create detailed biological pathways using genomic data and tools, with examples of hair and breast development.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Certain nutraceuticals may enhance hair growth without affecting the cancer-fighting properties of tamoxifen.

Hair growth-promoting nutraceuticals do not block the cancer-fighting effects of tamoxifen and may enhance its action.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

The document reports the first Brazilian case of a girl with Becker nevus syndrome, characterized by skin changes, breast underdevelopment, and scoliosis.

A girl with Becker's nevus syndrome showed good improvement in breast development using spironolactone.

Finasteride may cause breast enlargement, low testosterone a risk factor.

The analysis shows the U.S. leads in tissue expansion research, mainly for breast reconstruction, with a slightly higher complication rate when using acellular dermal matrix.

Hair loss during breast cancer treatment affects each woman differently, influenced by her environment and family.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Most patients tolerated spironolactone for acne and hirsutism despite common side effects like menstrual changes and breast tenderness.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.